{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:39:01Z","timestamp":1780094341608,"version":"3.54.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Prostate-specific membrane antigen (PSMA) PET findings of mixed ductal-acinar adenocarcinoma of the prostate are rarely reported. We describe <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/CT and delayed pelvic <jats:sup>18<\/jats:sup>F-PSMA-1007 PET\/MRI findings in a case of prostatic mixed ductal-acinar adenocarcinoma with multiple lymph node and bone metastases. The primary tumor showed heterogeneous PSMA uptake. The metastases in the right ilium and acetabulum showed intense PSMA uptake, but the pelvic lymph node and left iliac bone metastases showed no significant PSMA uptake. Knowledge of the intraprimary and intermetastatic heterogeneity of PSMA uptake in mixed ductal-acinar adenocarcinoma of the prostate may be helpful for accurate interpretation.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004742","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T23:00:07Z","timestamp":1686265207000},"page":"750-752","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Prostate-Specific Membrane Antigen Uptake Heterogeneity in Mixed Ductal-Acinar Adenocarcinoma of the Prostate"],"prefix":"10.1097","volume":"48","author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushu","family":"Bai","sequence":"additional","affiliation":[{"name":"Orthopedics, The First Affiliated Hospital (Changhai Hospital) of Naval Medical University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjing","family":"Zuo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/jcm11175064","article-title":"Primary staging of prostate cancer patients with [18F]PSMA-1007 PET\/CT compared with [68Ga]Ga-PSMA-11 PET\/CT","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0000000000004430","article-title":"Comparison of 18F-PSMA-1007 PET\/CT with 68Ga-PSMA-11 PET\/CT for initial staging in intermediate- and high-risk prostate Cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00259-021-05520-y","article-title":"Prospective intra-individual blinded comparison of [18F]PSMA-1007 and [68Ga]Ga-PSMA-11 PET\/CT imaging in patients with confirmed prostate cancer","volume":"49","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2967\/jnumed.116.183483","article-title":"The clinical impact of additional late PET\/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer","volume":"58","year":"2017","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3390\/cancers12102788","article-title":"Dual-time point [68Ga]Ga-PSMA-11 PET\/CT hybrid imaging for staging and restaging of prostate cancer","volume":"12","year":"2020","journal-title":"Cancers (Basel)"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/1754-9485.12605","article-title":"Flourodeoxyglucose positron emission tomography scan may be helpful in the case of ductal variant prostate cancer when prostate specific membrane antigen ligand positron emission tomography scan is negative","volume":"61","year":"2017","journal-title":"J Med Imaging Radiat Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/RLU.0000000000001329","article-title":"Non-prostate-specific membrane antigen-avid metastatic lung nodule from primary prostatic adenocarcinoma","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1097\/RLU.0000000000004230","article-title":"68Ga-PSMA-11 and 18F-FDG PET\/CT in a case of ductal adenocarcinoma of the prostate","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4103\/UA.UA_11_19","article-title":"Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression","volume":"11","year":"2019","journal-title":"Urol Ann"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41585-021-00447-3","article-title":"Optimizing the diagnosis and management of ductal prostate cancer","volume":"18","year":"2021","journal-title":"Nat Rev Urol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0b013e31820eb25b","article-title":"Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma","volume":"35","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/PAI.0000000000000110","article-title":"PSMA expression is highly homogenous in primary prostate cancer","volume":"23","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12253-008-9104-2","article-title":"Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis","volume":"15","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2967\/jnmt.118.215582","article-title":"Small cell transformation of metastatic prostate adenocarcinoma diagnosed by dual-tracer PET\/CT (68Ga-PSMA and 18F-FDG): potential clinical utility in therapeutic decision making and treatment monitoring","volume":"47","year":"2019","journal-title":"J Nucl Med Technol"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"937713","DOI":"10.3389\/fonc.2022.937713","article-title":"Case report: 18F-PSMA PET\/CT scan in castration resistant prostate cancer with aggressive neuroendocrine differentiation","volume":"12","year":"2022","journal-title":"Front Oncol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1097\/RLU.0000000000002367","article-title":"Intertumoral heterogeneity of 18F-FDG and 68Ga-PSMA uptake in prostate cancer pulmonary metastases","volume":"44","year":"2019","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:05:32Z","timestamp":1750532732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004742","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}